Buy Provigil Online

Buy Provigil Online without prescription from $49.95
Buy Provigil Online

Time-of-Day Variation in Task Performance

More than a century ago, it was reported that the capacity for doing mental work varies throughout the day. Several empirical studies have revealed time of day variations in performance, with subtle differences between different tasks. Similarly, in participants that are exposed to 36-60 h of sustained wakefulness in controlled laboratory (or constant routine) conditions, significant time of day variations in task performance are reported, with performance being worst for all tasks just after the time of core body temperature minimum (about 0400-0600 h). Subjective alertness levels are closely related to the time-of-day variation in task performance.

In the UK, as in many other countries, sleep-related vehicle accidents peak in the second half of the night (0200-0600 h), and also show a very modest rise in the mid afternoon (1400-1600 h).(10) The modest rise in accidents in the mid afternoon (which is small compared with the nocturnal rise) could reflect the post-lunch decrement in performance.(8) When variation in traffic density is taken into account, the likelihood of a sleep-related vehicle accident is 20 times higher at 0600 h than at 1000 h. Similarly, the risk of injury and fatality during the night shift is significantly greater than it is during traditional daytime working hours.(4,11) The cause of such accidents and injuries is often multifaceted, and the precise contribution of sleepiness is difficult to estimate.

Read more …

Sleep Disorders and Quality of Life

This article provides an overview of the daytime symptoms associated with the most common sleep disorders, namely insomnia, restless legs syndrome, obstructive sleep apnea syndrome and shift wake-sleep disorder.

Psychological and social dysfunction resulting from these sleep disturbances are explained and discussed in detail. Health-related quality of life is a concept that reflects the changes in diverse aspects of subjective wellbeing of the patients due to an illness.

Therefore, studies reporting quality-of-life issues associated with the aforementioned sleep disorders will also be presented. Finally, we review the limited data regarding the effects of treatment on quality-of-life outcomes.

Many patients with sleep disorders seek medical attention because of daytime symptoms or negative consequences of sleep disruption, which suggests that the night-time symptoms may be less bothersome than the daytime consequences of sleep problems.

Read more …

Provigil and Weight Loss

“Half of the clinical studies of potential pharmacologic interventions to prevent olanzapine-associated weight gain have been negative, at huge expense. We hope that this approach will help identify drugs with a better chance of working,” lead investigator James L. Roerig, PharmD, from the University of North Dakota School of Medicine, in Fargo, told Medscape Psychiatry.

The method developed by Dr. Roerig and colleagues uses brief placebo-controlled trials with normal volunteers to determine whether a prospective treatment drug deserves study in clinical trials.

The process starts with a brief trial to show that the main treatment agent will produce the target adverse effect in normal volunteers; it is followed by a short placebo-controlled study to see whether adding the candidate drug reduces the adverse effect enough in normal volunteers to signal that the test drug is likely to work and deserves further study.

Read more …

Stimulants to Treat Sleepness in Narcolepsy

These compounds have little effect on rapid eye movement (REM) sleep-related symptoms such as cataplexy, and antidepressants (monoamine uptake inhibitors) are usually required to treat these symptoms.

Although amphetamine-like stimulants and antidepressants enhance monoaminergic transmission, these compounds are non-selective for each monoamine, and the exact mechanisms mediating how these compounds induce wakefulness and modulate REM sleep are not known.

In order to evaluate the relative importance of dopaminergic and noradrenergic transmission in the mediation of these effects, five dopamine (DA) uptake inhibitors (mazindol, GBR-12909, bupropion, nomifensine and amineptine), two norepinephrine (NE) uptake inhibitors (nisoxetine and desipramine), d-amphetamine, and Provigil, a non-amphetamine stimulant, were tested in control and narcoleptic canines.

Read more …

Page 1 of 3123